Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age30-75

SponsorSohag University

About this trial

Study the relation between irisin level and progression of diabetic nephropathy and its early detection.

None

Non-diabetic kidney diseases.

Acute illness, infection, obesity, hypertension, type 1 DM.

Malignancy, other endocrine disorders, corticosteroid drugs, pregnancy, lactation.

No treatment groups listed

This trial has no locations

Sohag University

Lead sponsor